Document is current
Any future updates will be listed below
-
Authors
Diab, Olivia
DePierro, Jonathan https://orcid.org/0000-0002-6883-5026
Cancelmo, Leo
Schaffer, Jamie
Schechter, Clyde
Dasaro, Christopher R.
Todd, Andrew
Crane, Michael
Udasin, Iris
Harrison, Denise
Moline, Jacqueline
Luft, Benjamin
Southwick, Steven M.
Feder, Adriana
Pietrzak, Robert H.
-
Funding
Funding for this research was provided by:
National Institute for Occupational Safety and Health (200-2011-41919, 200-2017-93325)
- License Information
-
More Information
Article History
First Online: 27 November 2019
Compliance with Ethical Standards
:
: Dr. Feder (co-inventor) and Mount Sinai have been named on a use patent application of ketamine for the treatment of posttraumatic stress disorder; patent is currently pending. Dr. Schechter has received consulting fees from Accolade, Inc., for analysis of claims data in evaluation of the effectiveness of their services and for technical support provided to in-house statistical staff. Dr. Pietrzak is a scientific consultant to CogState Ltd. Drs. DePierro, Crane, Harrison, Luft, Moline, and Southwick and Ms. Diab, Ms. Schaffer and Mr. Cancelmo report no competing interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Mount Sinai Program for the Protection of Human Subjects, HS#: 11-01635) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
